NICE recommends targeted treatment for neuroendocrine cancer in the liver
Posted:
People with neuroendocrine tumours (NETs) in the liver could benefit from a therapy that targets tumours with radiation while limiting exposure to healthy surrounding tissue, according to new guidance from the National Institute for Health and Care Excellence (NICE). NETs are cancers of neuroendocrine cells commonly spread from organs such as the gastrointestinal tract or pancreas to the liver. The guidance is significant as it offers another option for healthcare professionals to treat patients within the National Health Service in England and Wales.
ChatEHR, artificial intelligence software developed at Stanford Medicine, is expediting chart reviews and other tasks by allowing clinicians to ask questions of medical records.
Read more here.
As meaning-makers, we use spoken or signed language to understand our experiences in the world around us. The emergence of generative artificial intelligence such as ChatGPT (using large language models) call into question the very notion of how to define “meaning.”
Read more here.